Preclina is a non-clinical CRO with a fully-integrated drug discovery platform specialized in autoimmune disorders and inflammatory conditions, based on our core skills in immunology and extensive expertise in patient-derived cells and animal models recapitulating these disorders.
As a CRO that delivers extraordinary values to various pharmaceutical companies, bio companies, and researchers all around the world, we collaborate with our clients to successfully develop new drugs and diagnostic / treatment technologies.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 연구수 송도과학로32 송도테크노파크 It 센터, S 동 3003호, 인천시,21984,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.preclina.com
- Keywords
- Nonclinical CRO, Pharmacology, Immunology, Autoimmune disorders, Inflammatory disorders, Patient-derived cell function study, Target validation, Arthritis research, Fibrosis research, Animal experiments, Toxicology, PK/ADME, Histopathology.
- HQ
- 인천시
Preclina Questions
Preclina's website is http://www.preclina.com
Preclina's LinkedIn profile is https://kr.linkedin.com/company/preclina
Preclina has
6 employees.
View email and phone details for 6
employees at Preclina.
Preclina's industry is
Biotechnology Research
Preclina's top competitors are
Abc Biopply Ag,
Fromthered,
Rudacure,
Vault Pharma,
Sobi Switzerland,
Novatia, Llc,
Curome Biosciences,
Decodecell,
Gut Research,
Umtr.
Preclina's categories are Biotechnology Research
Preclina's founding year is 2018
